Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance-Reference-Cited by-同舟云学术

Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance

Published:2020-11-12 Issue: Volume: Page:1-15
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Kasper Siegfried¹,Cubała Wiesław J.²,Fagiolini Andrea³,Ramos-Quiroga Josep A.⁴⁵⁶⁷^ORCID,Souery Daniel⁸^ORCID,Young Allan H.⁹^ORCID

Affiliation:

1. Center for Brain Research, Medical University of Vienna, Vienna, Austria

2. Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland

3. Department of Molecular Medicine, University of Siena, Siena, Italy

4. Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain

5. Group of Psychiatry, Mental Health and Addictions, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain

6. Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain

7. Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

8. European Centre of Psychological Medicine, Psy Pluriel, Brussels, Belgium

9. Department of Psychological Medicine, King’s College London, London, UK

Funder

Janssen Pharmaceutica NV

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15622975.2020.1836399

Reference82 articles.

1. Treatment-resistant depression: therapeutic trends, challenges, and future directions

2. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey

3. Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

4. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

5. Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-02

2. Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach;Journal of Psychiatric Research;2024-02

3. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis;Frontiers in Psychiatry;2024-02-01

4. Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries;Middle East Current Psychiatry;2023-12-07

5. Overcoming the myths of esketamine administration: different and not difficult;Frontiers in Psychiatry;2023-11-23